Amgen officer Derek Miller plans $1.57M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amgen Inc. officer Derek Miller’s Form 144 notice lists a planned sale of 3,890 common shares, with an aggregate market value of $1,574,866.50 and an approximate sale date of August 6, 2026. The shares are listed as acquired from the issuer as compensation through stock options on August 6, 2026, with payment described as a cashless exercise / same-day sale. Goldman Sachs & Co. LLC signed on Miller’s behalf.
Key Figures
Key Terms
Stock Options financial
Cashless exercise / same-day sale financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.